SSPL WEALTH PVT LTD

Saturday 23 Nov, 2024 04:24 PM

Waaree Technologies bags order for 530 solar kits National Fertilizers plans to launch of nano liquid urea production Cochin Shipyard inks MoU with Seatrium Letourneau, USA H.G. Infra bags LoA for 500-MW Battery Storage Project Zaggle partners with Golden Jasraj Music Platforms Rites revises estimate for Northeast Frontier Railway electrification to Rs 532 cr NSE SME Onyx Biotec slips on debut Godrej Inds rises after board OKs NCD issue worth Rs 1,000 cr Insolation Energy gains as arm inks MoU with Govt of Rajasthan Adani Green Energy Ltd leads losers in 'A' group Protean eGov Technologies Ltd leads losers in 'B' group Raymond spurts after realty biz demerger plan gets BSE, NSE nod Volumes jump at Sun Pharma Advanced Research Company Ltd counter Bata India gains on appointing Durgesh Singh as CFO Protean eGov Tech tumbles after OFS opens for non-retail investors

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Marksans Pharma gains after receiving final nod for Loratadine Tablets from USFDA

22-Nov-24 13:23 Hrs IST

The said drugs are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use. Loratadine is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from hay fever and other allergies.

This product is generic version of Clartin tablet in the same strength of Bayer Healthcare.

Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.

The company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 over Q2 FY24.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 37046656

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)